"A trajetória do Hospital de Clínicas completou 105 anos no dia 20 de julho de 2019, unificando a experiência no atendimento em saúde e a inovação contínua dos processos e serviços. Com a missão institucional de promover melhorias na qualidade de vida das pessoas, por meio de ações integradas de assistência à saúde, ensino e pesquisa, o Hospital de Clínicas se consolida como referência macrorregional para o atendimento a uma população de mais de cento e quarenta municípios da região Norte do Rio Grande do Sul e Oeste de Santa Catarina."

During the past decade, Hospital Da Cidade de Passo Fundo conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Da Cidade de Passo Fundo" #1 sponsor was "Daiichi Sankyo, Inc." with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Alaunos Therapeutics" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Eurofarma Laboratorios S.A." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Da Cidade de Passo Fundo" #1 collaborator was "Innogene Kalbiotech Pte. Ltd" with 2 trials as a collaborator, "Laboratorio Elea Phoenix S.A." with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "CIMAB (Cuba)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Da Cidade de Passo Fundo" are "Acute Myeloid Leukemia" (1 trials), "Adenocarcinoma" (1 trials), "Advanced Breast Cancer Female" (1 trials), "Cancer of the Prostate" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hospital Da Cidade de Passo Fundo" in a lesser frequency.

Most popular intervention types in "Hospital Da Cidade de Passo Fundo" are "Drug" (10 trials), "Other" (5 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Avastin" (1 trials), "BBI608" (1 trials), "BI 695502" (1 trials) and "Best Support Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Da Cidade de Passo Fundo" are 11 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Da Cidade de Passo Fundo". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Da Cidade de Passo Fundo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Da Cidade de Passo Fundo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".